MIC Gen 5 Hemostatic Tourniquet — for stopping massive bleeding
MIC Gen 5 Hemostatic Tourniquet — a reliable and proven tactical medicine device for quick and effective stopping of massive bleeding from upper and lower extremities.
According to the MARCH protocol, a hemostatic tourniquet is used for first aid on the battlefield in cases of massive bleeding. Specifically, in the "red" zone, it is the primary recommended action.
Advantages and Features
Stable non-sticky triangular tail:
Easy to grasp and thread through the buckle for the first pass, even in zero visibility.
Single-channel metal buckle with bend and 2 rows of teeth:
Ensures reliable strap fixation, minimizes skin pinching and soft tissue injury, stable (does not twist).
Open stabilization platform with stiffening ribs, covered with tape underneath:
Transversely rigid, withstands significant loads without deformation, gently distributes pressure, prevents the strap from knotting.
Elastic concave C-clips:
Securely and quickly fix the windlass.
Protectors before and after the platform:
Prevent skin pinching, minimize points of increased pressure, injury, and pain.
Reinforced single inner strap:
Smoother growth (compared to double) and even pressure distribution. High strength and wear resistance. Smaller knot under the windlass (allows more turns).
Durable ribbed windlass made of reinforced polymer:
Withstands extreme loads, resistant to breakage. Ergonomic and comfortable, does not slip in hand.
Upper protective strap:
Holds the windlass in the C-clips. Does not glare or unmask. Space for time notation.
Windlass travel stopper on the inner strap:
Facilitates effective tourniquet application to limbs of small circumference.
Specifications
Brand: MIC (Medical Innovation Center).
Manufacturer: CityLab, Ukraine.
Width: 38 mm.
Length: 975 mm.
Weight: 108 g.
Purpose: stopping massive bleeding from upper and lower extremities.
There are no reviews for this product, be the first to leave your review.
No questions about this product, be the first and ask your question.